{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:47:06Z","timestamp":1785822426010,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology foundation of Liaoning, China","award":["2023JH2\/101300045"],"award-info":[{"award-number":["2023JH2\/101300045"]}]},{"name":"the Science and Technology foundation of Shenyang, China","award":["223213307"],"award-info":[{"award-number":["223213307"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07618-5","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:55:19Z","timestamp":1767419719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1"],"prefix":"10.1186","volume":"24","author":[{"given":"Shuyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"7618_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020, (n.d.). https:\/\/doi.org\/10.1093\/neuonc\/noad149 (accessed September 23, 2025).","DOI":"10.1093\/neuonc\/noad149"},{"key":"7618_CR2","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.7150\/thno.41219","volume":"10","author":"B Han","year":"2020","unstructured":"Han B, Meng X, Wu P, Li Z, Li S, Zhang Y, Zha C, Ye Q, Jiang C, Cai J, Jiang T. ATRX\/EZH2 complex epigenetically regulates FADD\/PARP1 axis, contributing to TMZ resistance in glioma. Theranostics. 2020;10:3351\u201365. https:\/\/doi.org\/10.7150\/thno.41219.","journal-title":"Theranostics"},{"key":"7618_CR3","doi-asserted-by":"publisher","first-page":"e939","DOI":"10.1002\/ctm2.939","volume":"12","author":"M Verreault","year":"2022","unstructured":"Verreault M, Segoviano Vilchis I, Rosenberg S, Lemaire N, Schmitt C, Guehennec J, Royer-Perron L, Thomas J, Lam TT, Dingli F, Loew D, Ducray F, Paris S, Carpentier C, Marie Y, Laigle\u2010Donadey F, Rousseau A, Pigat N, Boutillon F, Bielle F, Mokhtari K, Frank SJ, de Reyni\u00e8s A, Hoang\u2010Xuan K, Sanson M, Goffin V, Idbaih A. Identification of growth hormone receptor as a relevant target for precision medicine in low\u2010EGFR expressing glioblastoma. Clin Transl Med. 2022;12:e939. https:\/\/doi.org\/10.1002\/ctm2.939.","journal-title":"Clin Transl Med"},{"key":"7618_CR4","doi-asserted-by":"publisher","first-page":"106290","DOI":"10.1016\/j.phrs.2022.106290","volume":"181","author":"F Cucchiara","year":"2022","unstructured":"Cucchiara F, Luci G, Giannini N, Giorgi FS, Orlandi P, Banchi M, Di Paolo A, Pasqualetti F, Danesi R, Bocci G. Association of plasma Levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients. Pharmacol Res. 2022;181:106290. https:\/\/doi.org\/10.1016\/j.phrs.2022.106290.","journal-title":"Pharmacol Res"},{"key":"7618_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"key":"7618_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13046-024-03038-3","volume":"43","author":"P Yu","year":"2024","unstructured":"Yu P, Xu T, Ma W, Fang X, Bao Y, Xu C, Huang J, Sun Y, Li G. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and Emt via the wnt\u2013\u03b2-catenin pathway. J Exp Clin Cancer Res. 2024;43:116. https:\/\/doi.org\/10.1186\/s13046-024-03038-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"7618_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-06920-2","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Shen S, You J, Wang Z, Li Y, Chen Y, Tuo Y, Chen D, Yu H, Zhang J, Wang F, Pang X, Xiao Z, Lan Q, Wang Y. PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration. Cell Death Dis. 2024;15:1\u201313. https:\/\/doi.org\/10.1038\/s41419-024-06920-2.","journal-title":"Cell Death Dis"},{"key":"7618_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","volume":"20","author":"E Guccione","year":"2019","unstructured":"Guccione E, Richard S. The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019;20:642\u201357. https:\/\/doi.org\/10.1038\/s41580-019-0155-x.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7618_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12967-025-06097-y","volume":"23","author":"X Zhang","year":"2025","unstructured":"Zhang X, Jin M, Chu Y, Liu F, Qu H, Chen C. PRMT6 promotes colorectal cancer progress via activating MYC signaling. J Transl Med. 2025;23:74. https:\/\/doi.org\/10.1186\/s12967-025-06097-y.","journal-title":"J Transl Med"},{"key":"7618_CR10","doi-asserted-by":"publisher","first-page":"14894","DOI":"10.1073\/pnas.1312925110","volume":"110","author":"F Casadio","year":"2013","unstructured":"Casadio F, Lu X, Pollock SB, LeRoy G, Garcia BA, Muir TW, Roeder RG, Allis CD. H3R42me2a is a histone modification with positive transcriptional effects. Proc Natl Acad Sci U S A. 2013;110:14894\u20139. https:\/\/doi.org\/10.1073\/pnas.1312925110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7618_CR11","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.celrep.2018.08.052","volume":"24","author":"Genomic location","year":"2018","unstructured":"Genomic location. Of PRMT6-dependent H3R2 methylation is linked to the transcriptional outcome of associated genes. Cell Rep. 2018;24:3339\u201352. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.052.","journal-title":"Cell Rep"},{"key":"7618_CR12","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/nar\/gkp1203","volume":"38","author":"MJ Harrison","year":"2010","unstructured":"Harrison MJ, Tang YH, Dowhan DH. Protein arginine methyltransferase 6 regulates multiple aspects of gene expression. Nucleic Acids Res. 2010;38:2201\u201316. https:\/\/doi.org\/10.1093\/nar\/gkp1203.","journal-title":"Nucleic Acids Res"},{"key":"7618_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molcel.2006.02.013","volume":"22","author":"N El-Andaloussi","year":"2006","unstructured":"El-Andaloussi N, Valovka T, Toueille M, Steinacher R, Focke F, Gehrig P, Covic M, Hassa PO, Sch\u00e4r P, H\u00fcbscher U, Hottiger MO. Arginine methylation regulates DNA polymerase \u03b2. Mol Cell. 2006;22:51\u201362. https:\/\/doi.org\/10.1016\/j.molcel.2006.02.013.","journal-title":"Mol Cell"},{"key":"7618_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-06148-6","volume":"14","author":"Q Chen","year":"2023","unstructured":"Chen Q, Hu Q, Chen Y, Shen N, Zhang N, Li A, Li L, Li J. PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer. Cell Death Dis. 2023;14:1\u201315. https:\/\/doi.org\/10.1038\/s41419-023-06148-6.","journal-title":"Cell Death Dis"},{"key":"7618_CR15","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1093\/nar\/gky103","volume":"46","author":"L Huang","year":"2018","unstructured":"Huang L, Wang Z, Narayanan N, Yang Y. Arginine methylation of the C-terminus RGG motif promotes TOP3B topoisomerase activity and stress granule localization. Nucleic Acids Res. 2018;46:3061\u201374. https:\/\/doi.org\/10.1093\/nar\/gky103.","journal-title":"Nucleic Acids Res"},{"key":"7618_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1096\/fj.06-6194com","volume":"21","author":"N El-Andaloussi","year":"2007","unstructured":"El-Andaloussi N, Valovka T, Toueille M, Hassa PO, Gehrig P, Covic M, H\u00fcbscher U, Hottiger MO. Methylation of DNA polymerase \u00df by protein arginine methyltransferase 1 regulates its binding to proliferating cell nuclear antigen. FASEB J. 2007;21:26\u201334. https:\/\/doi.org\/10.1096\/fj.06-6194com.","journal-title":"FASEB J"},{"key":"7618_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-020-01641-8","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan F, Xu Y, Cai Q, Geng R, Chen Q. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma. J Exp Clin Cancer Res. 2020;39:137. https:\/\/doi.org\/10.1186\/s13046-020-01641-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"7618_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.020.","journal-title":"Cancer Lett"},{"key":"7618_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/hep.30923","volume":"71","author":"T-L Wong","year":"2020","unstructured":"Wong T-L, Ng K-Y, Tan KV, Chan L-H, Zhou L, Che N, Hoo RLC, Lee TK, Richard S, Lo C-M, Man K, Khong P-L, Ma S. CRAF methylation by PRMT6 regulates aerobic glycolysis\u2013driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation. Hepatology. 2020;71:1279. https:\/\/doi.org\/10.1002\/hep.30923.","journal-title":"Hepatology"},{"key":"7618_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/cancers16061131","volume":"16","author":"H Zhang","year":"2024","unstructured":"Zhang H, Ma\u00f1\u00e1n-Mej\u00edas PM, Miles HN, Putnam AA, MacGillivray LR, Ricke WA. DDX3X and stress granules: emerging players in cancer and drug resistance. Cancers. 2024;16:1131. https:\/\/doi.org\/10.3390\/cancers16061131.","journal-title":"Cancers"},{"key":"7618_CR21","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.cell.2023.05.047","volume":"186","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, Li W, Xue J, Zhou K, Sun M, Tan B, Chen Z, Shen C, Gao L, Small A, Wang K, Leung K, Zhang Z, Qin X, Deng X, Xia Q, Su R, Chen J. QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023;186:3208\u2013e322627. https:\/\/doi.org\/10.1016\/j.cell.2023.05.047.","journal-title":"Cell"},{"key":"7618_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13578-023-01030-6","volume":"13","author":"H Zhou","year":"2023","unstructured":"Zhou H, Luo J, Mou K, Peng L, Li X, Lei Y, Wang J, Lin S, Luo Y, Xiang L. Stress granules: functions and mechanisms in cancer. Cell Biosci. 2023;13:86. https:\/\/doi.org\/10.1186\/s13578-023-01030-6.","journal-title":"Cell Biosci"},{"key":"7618_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40880-019-0424-2","volume":"39","author":"J-H Tang","year":"2019","unstructured":"Tang J-H, Yang L, Chen J-X, Li Q-R, Zhu L-R, Xu Q-F, Huang G-H, Zhang Z-X, Xiang Y, Du L, Zhou Z, Lv S-Q. Bortezomib inhibits growth and sensitizes glioma to Temozolomide (TMZ) via down-regulating the FOXM1\u2013survivin axis. Cancer Commun. 2019;39:81. https:\/\/doi.org\/10.1186\/s40880-019-0424-2.","journal-title":"Cancer Commun"},{"key":"7618_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O\u2019Kelly M, Tamayo P, Weir BA, Gabrie S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell. 2010;17:98. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020.","journal-title":"Cancer Cell"},{"key":"7618_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin Y-H, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Sauv\u00e9 C-EG, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam D-H, Verhaak RGW. Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment. Cancer Cell. 2017;32:42\u2013e566. https:\/\/doi.org\/10.1016\/j.ccell.2017.06.003.","journal-title":"Cancer Cell"},{"key":"7618_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","volume":"41","author":"L Barthel","year":"2022","unstructured":"Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Sure U, Thakur BK, Hetze S. Glioma: molecular signature and crossroads with tumor microenvironment. Cancer Metastasis Rev. 2022;41:53\u201375. https:\/\/doi.org\/10.1007\/s10555-021-09997-9.","journal-title":"Cancer Metastasis Rev"},{"key":"7618_CR27","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1093\/nar\/gku264","volume":"42","author":"C Kaehler","year":"2014","unstructured":"Kaehler C, Isensee J, Hucho T, Lehrach H, Krobitsch S. 5-fluorouracil affects assembly of stress granules based on RNA incorporation. Nucleic Acids Res. 2014;42:6436\u201347. https:\/\/doi.org\/10.1093\/nar\/gku264.","journal-title":"Nucleic Acids Res"},{"key":"7618_CR28","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1093\/nar\/gku530","volume":"42","author":"A Di Lorenzo","year":"2014","unstructured":"Di Lorenzo A, Yang Y, Macaluso M, Bedford MT. A gain-of-function mouse model identifies PRMT6 as a NF-\u03baB coactivator. Nucleic Acids Res. 2014;42:8297\u2013309. https:\/\/doi.org\/10.1093\/nar\/gku530.","journal-title":"Nucleic Acids Res"},{"key":"7618_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41389-021-00332-z","volume":"10","author":"L Schneider","year":"2021","unstructured":"Schneider L, Herkt S, Wang L, Feld C, Wesely J, Kuvardina ON, Meyer A, Oellerich T, H\u00e4upl B, Seifried E, Bonig H, Lausen J. PRMT6 activates Cyclin D1 expression in conjunction with the transcription factor LEF1. Oncogenesis. 2021;10:42. https:\/\/doi.org\/10.1038\/s41389-021-00332-z.","journal-title":"Oncogenesis"},{"key":"7618_CR30","doi-asserted-by":"publisher","unstructured":"Gao X, Jiang L, Gong Y, Chen X, Ying M, Zhu H, He Q, Yang B, Cao J. Stress granule: a promising target for cancer treatment. Br J Pharmacol. 2019;176(22):4286\u20134300. https:\/\/doi.org\/10.1111\/bph.14790.","DOI":"10.1111\/bph.14790"},{"key":"7618_CR31","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ncb1791","volume":"10","author":"K Arimoto","year":"2008","unstructured":"Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol. 2008;10:1324\u201332. https:\/\/doi.org\/10.1038\/ncb1791.","journal-title":"Nat Cell Biol"},{"key":"7618_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00763-12","author":"M Takahashi","year":"2013","unstructured":"Takahashi M, Higuchi M, Matsuki H, Yoshita M, Ohsawa T, Oie M, Fujii M. Stress granules inhibit apoptosis by reducing reactive oxygen species production. Mol Cell Biol. 2013. https:\/\/doi.org\/10.1128\/MCB.00763-12.","journal-title":"Mol Cell Biol"},{"key":"7618_CR33","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.3892\/mmr.2020.11527","volume":"22","author":"Y Li","year":"2020","unstructured":"Li Y, Wang J, Zhong S, Li J, Du W. Overexpression of G3BP1 facilitates the progression of colon cancer by activating \u03b2\u2013catenin signaling. Mol Med Rep. 2020;22:4403\u201311. https:\/\/doi.org\/10.3892\/mmr.2020.11527.","journal-title":"Mol Med Rep"},{"key":"7618_CR34","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1038\/sj.onc.1210212","volume":"26","author":"MM Kim","year":"2007","unstructured":"Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan Z-M. Modulation of p53 and MDM2 activity by novel interaction with ras-GAP binding proteins (G3BP). Oncogene. 2007;26:4209\u201315. https:\/\/doi.org\/10.1038\/sj.onc.1210212.","journal-title":"Oncogene"},{"key":"7618_CR35","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/onc.2014.194","volume":"34","author":"N Oi","year":"2015","unstructured":"Oi N, Yuan J, Malakhova M, Luo K, Li Y, Ryu J, Zhang L, Bode AM, Xu Z, Li Y, Lou Z, Dong Z. Resveratrol induces apoptosis by directly targeting ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene. 2015;34:2660\u201371. https:\/\/doi.org\/10.1038\/onc.2014.194.","journal-title":"Oncogene"},{"key":"7618_CR36","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1158\/0008-5472.CAN-17-3454","volume":"78","author":"C Mao","year":"2018","unstructured":"Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang Y, Shi Y, Shen Y, Liu X, Lai W, Yang R, Xiao D, Cheng Y, Liu S, Zhou H, Cao Y, Yu W, Muegge K, Yu H, Tao Y. A G3BP1-interacting LncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 2018;78:3484\u201396. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3454.","journal-title":"Cancer Res"},{"key":"7618_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41416-020-01067-1","volume":"124","author":"J Zhao","year":"2021","unstructured":"Zhao J, Fu X, Chen H, Min L, Sun J, Yin J, Guo J, Li H, Tang Z, Ruan Y, Wang X, Sun Y, Huang L. G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer. Br J Cancer. 2021;124:425\u201336. https:\/\/doi.org\/10.1038\/s41416-020-01067-1.","journal-title":"Br J Cancer"},{"key":"7618_CR38","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1093\/nar\/gkaa376","volume":"48","author":"SP Somasekharan","year":"2020","unstructured":"Somasekharan SP, Zhang F, Saxena N, Huang JN, Kuo I-C, Low C, Bell R, Adomat H, Stoynov N, Foster L, Gleave M, Sorensen PH. G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress. Nucleic Acids Res. 2020;48:6855\u201373. https:\/\/doi.org\/10.1093\/nar\/gkaa376.","journal-title":"Nucleic Acids Res"},{"key":"7618_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1083\/jcb.201609081","volume":"215","author":"MD Panas","year":"2016","unstructured":"Panas MD, Ivanov P, Anderson P. Mechanistic insights into mammalian stress granule dynamics. J Cell Biol. 2016;215:313\u201323. https:\/\/doi.org\/10.1083\/jcb.201609081.","journal-title":"J Cell Biol"},{"key":"7618_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1179\/1743132814Y.0000000423","volume":"37","author":"D Nanegrungsunk","year":"2015","unstructured":"Nanegrungsunk D, Onchan W, Chattipakorn N, Chattipakorn SC. Current evidence of Temozolomide and bevacizumab in treatment of gliomas. Neurol Res. 2015;37:167\u201383. https:\/\/doi.org\/10.1179\/1743132814Y.0000000423.","journal-title":"Neurol Res"},{"key":"7618_CR41","doi-asserted-by":"publisher","unstructured":"Liu X, Xie P, Hao N, Zhang M, Liu Y, Liu P, Semenza GL, He J, Zhang H. HIF-1\u2013regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt\/\u03b2-catenin pathway activation. Proc Natl Acad Sci USA. 2021;118:e2109144118. https:\/\/doi.org\/10.1073\/pnas.2109144118.","DOI":"10.1073\/pnas.2109144118"},{"key":"7618_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/1440-1681.12581","volume":"43","author":"S-T Pan","year":"2016","unstructured":"Pan S-T, Li Z-L, He Z-X, Qiu J-X, Zhou S-F. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol. 2016;43:723\u201337. https:\/\/doi.org\/10.1111\/1440-1681.12581.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"7618_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153\u201364. https:\/\/doi.org\/10.1016\/S0092-8674(02)00625-6.","journal-title":"Cell"},{"key":"7618_CR44","doi-asserted-by":"publisher","first-page":"e95371","DOI":"10.1371\/journal.pone.0095371","volume":"9","author":"H-Y Xu","year":"2014","unstructured":"Xu H-Y, Xu W-L, Wang L-Q, Chen M-B, Shen H-L. Relationship between P53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis. PLoS ONE. 2014;9:e95371. https:\/\/doi.org\/10.1371\/journal.pone.0095371.","journal-title":"PLoS ONE"},{"key":"7618_CR45","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","volume":"15","author":"MH Kang","year":"2009","unstructured":"Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy, clin. Cancer Res. 2009;15:1126\u201332. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0144.","journal-title":"Cancer Res"},{"key":"7618_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11060-019-03252-6","volume":"144","author":"LFF Bittencourt","year":"2019","unstructured":"Bittencourt LFF, Negreiros-Lima GL, Sousa LP, Silva AG, Souza IBS, Ribeiro RIMA, Dutra MF, Silva RF, Dias ACF, Soriani FM, Martins WK, Barcelos LS. G3BP1 knockdown sensitizes U87 glioblastoma cell line to bortezomib by inhibiting stress granules assembly and potentializing apoptosis. J Neuro-Oncol. 2019;144:463\u201373. https:\/\/doi.org\/10.1007\/s11060-019-03252-6.","journal-title":"J Neuro-Oncol"},{"key":"7618_CR47","doi-asserted-by":"publisher","first-page":"115834","DOI":"10.1016\/j.bcp.2023.115834","volume":"217","author":"C Liu","year":"2023","unstructured":"Liu C, Zhou L, Chen J, Yang Z, Chen S, Wang X, Liu X, Li Y, Zhang C, Wang Y, Chen Y, Li H, Shen C, Sun H. Galectin-7 promotes cisplatin efficacy by facilitating apoptosis and G3BP1 degradation in cervical cancer. Biochem Pharmacol. 2023;217:115834. https:\/\/doi.org\/10.1016\/j.bcp.2023.115834.","journal-title":"Biochem Pharmacol"},{"key":"7618_CR48","doi-asserted-by":"publisher","first-page":"216305","DOI":"10.1016\/j.canlet.2023.216305","volume":"569","author":"P Zhao","year":"2023","unstructured":"Zhao P, Yuan F, Xu L, Jin Z, Liu Y, Su J, Yuan L, Peng L, Wang C, Zhang G. HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex. Cancer Lett. 2023;569:216305. https:\/\/doi.org\/10.1016\/j.canlet.2023.216305.","journal-title":"Cancer Lett"},{"key":"7618_CR49","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.molcel.2021.01.015","volume":"81","author":"T Huang","year":"2021","unstructured":"Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A, Liu F, Brennan CW, Kessler JA, Stupp R, Nakano I, Sulman EP, Nishikawa R, James CD, Zhang W, Xu W, Hu B, Cheng S-Y. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Mol Cell. 2021;81:1276\u2013e12919. https:\/\/doi.org\/10.1016\/j.molcel.2021.01.015.","journal-title":"Mol Cell"},{"key":"7618_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbi.2024.02.027","volume":"118","author":"T Hua","year":"2024","unstructured":"Hua T, Kong E, Zhang H, Lu J, Huang K, Ding R, Wang H, Li J, Han C, Yuan H. PRMT6 deficiency or Inhibition alleviates neuropathic pain by decreasing Glycolysis and inflammation in microglia. Brain Behav Immun. 2024;118:101\u201314. https:\/\/doi.org\/10.1016\/j.bbi.2024.02.027.","journal-title":"Brain Behav Immun"},{"key":"7618_CR51","doi-asserted-by":"publisher","unstructured":"Gupta N, Badeaux M, Liu Y, Naxerova K, Sgroi D, Munn LL, Jain RK, Garkavtsev I. Stress granule-associated protein G3BP2 regulates breast tumor initiation. Proc Natl Acad Sci USA. 2017;114:1033\u20131038. https:\/\/doi.org\/10.1073\/pnas.1525387114.","DOI":"10.1073\/pnas.1525387114"},{"key":"7618_CR52","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1074\/jbc.RA118.002046","volume":"293","author":"B Ramachandran","year":"2018","unstructured":"Ramachandran B, Stabley JN, Cheng S-L, Behrmann AS, Gay A, Li L, Mead M, Kozlitina J, Lemoff A, Mirzaei H, Chen Z, Towler DA. A GTPase-activating protein\u2013binding protein (G3BP1)\/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells. J Biol Chem. 2018;293:7942\u201368. https:\/\/doi.org\/10.1074\/jbc.RA118.002046.","journal-title":"J Biol Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07618-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:50:47Z","timestamp":1770979847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07618-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7618"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07618-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human participant component of this study was performed in accordance with the ethical standards of the Declaration of Helsinki and was approved by the Education and Ethics Committee of the First Affiliated Hospital of China Medical University. Written informed consent was obtained from all individual participants included in the study. All procedures involving animals were in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of China Medical University. All efforts were made to minimize animal suffering and to reduce the number of animals used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}